GSA Capital Partners’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,729
Closed -$489K 1957
2025
Q3
$489K Buy
4,729
+1,110
+31% +$109K 0.04% 863
2025
Q2
$451K Buy
+3,619
New +$467K 0.03% 997
2024
Q1
Sell
-3,382
Closed -$91K 1860
2023
Q4
$91K Buy
3,382
+1,357
+67% +$42.3K 0.01% 1402
2023
Q3
$62K Buy
+2,025
New +$97.7K 0.01% 1410

Other funds holding NUTX

GSA Capital Partners's NUTX Position: Q4 2025 in Review

GSA Capital Partners sold out of Nutex Health (NUTX) in Q4 2025, closing a stake of 4,729 shares — an estimated $489K sold.

GSA Capital Partners first reported a position in NUTX in Q3 2023 and held it in 4 quarters. The position peaked at $489K in Q3 2025. 117 funds tracked by Wall St. Rank hold NUTX as of Q4 2025.

  • GSA Capital Partners reported no remaining Nutex Health position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 4,729 Nutex Health shares in Q4 2025, an estimated $489K.
  • GSA Capital Partners first reported a position in Nutex Health in Q3 2023 and held it in 4 quarters.
  • GSA Capital Partners's Nutex Health position peaked at $489K in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Nutex Health as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.